Literature DB >> 7609578

On the simultaneous electrophysiological measurements of neurotransmitter release and perineural calcium currents from frog motor nerve endings.

R S Redman1, E M Silinsky.   

Abstract

Ca2+ currents from the perineural region of motor nerve endings were measured together with evoked acetylcholine (ACh) release (i.e., end-plate potentials EPPs) in frog skeletal muscle in an attempt to define experimental conditions in which simultaneous measurements of both phenomena were feasible. In a solution containing low Ca2+ (0.9 mM), high Mg2+ (10 mM) and modest concentrations of K+ channel blockers (250 microM tetraethylammonium, 100 microM 3,4,-diaminopyridine), reliable measurements of perineural Ca2+ currents were possible. For convenience, this solution will be termed 'Ca2+ current' Ringer. The mean number of ACh quanta released in Ca2+ current Ringer was near the midpoint of the relationship between extracellular [Ca2+] and evoked ACh release observed previously in normal Ringer solutions. Consequently, ACh release in response to low-frequency motor nerve stimulation (0.05 Hz) was well maintained, allowing simultaneous measurements of Ca2+ currents and evoked ACh release to be made. Ca2+ currents and EPPs measured simultaneously in Ca2+ current Ringer were increased or decreased in parallel by increasing or decreasing the extracellular Ca2+ concentrations. Ca2+ channel blockers (Cd2+, 500 microM; omega-conotoxin, 3 microM) eliminated both EPPs and the Ca2+ component of the perineural current. NaF (10 mM), which stimulates ACh release, produced parallel increases in EPPs and perineural Ca2+ currents. NG-cyclohexyladenosine (CHA), an A1 adenosine receptor agonist, inhibits ACh release without effects on perineural currents. The results suggest that the concurrent electrophysiological recording of Ca2+ currents and ACh release in Ca2+ current Ringer is a reliable experimental approach for determining whether drugs or disease states affect ACh release by acting on Ca2+ channels in the presynaptic membrane.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7609578     DOI: 10.1016/0165-0270(94)00133-2

Source DB:  PubMed          Journal:  J Neurosci Methods        ISSN: 0165-0270            Impact factor:   2.390


  7 in total

1.  The phosphatidylinositol 4-kinase inhibitor phenylarsine oxide blocks evoked neurotransmitter release by reducing calcium entry through N-type calcium channels.

Authors:  T J Searl; E M Silinsky
Journal:  Br J Pharmacol       Date:  2000-05       Impact factor: 8.739

2.  Opposing effects of phorbol esters on transmitter release and calcium currents at frog motor nerve endings.

Authors:  R S Redman; T J Searl; J K Hirsh; E M Silinsky
Journal:  J Physiol       Date:  1997-05-15       Impact factor: 5.182

3.  Inhibitory-excitatory synaptic balance is shifted toward increased excitation in magnocellular neurosecretory cells of heart failure rats.

Authors:  Evgeniy S Potapenko; Vinicia C Biancardi; Renea M Florschutz; Pan D Ryu; Javier E Stern
Journal:  J Neurophysiol       Date:  2011-06-22       Impact factor: 2.714

4.  Antagonism of calcium currents and neurotransmitter release by barium ions at frog motor nerve endings.

Authors:  E M Silinsky
Journal:  Br J Pharmacol       Date:  2000-01       Impact factor: 8.739

Review 5.  Phorbol esters and neurotransmitter release: more than just protein kinase C?

Authors:  Eugene M Silinsky; Timothy J Searl
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

6.  Ca2+-independent feedback inhibition of acetylcholine release in frog neuromuscular junction.

Authors:  Inna Slutsky; Grigory Rashkovan; Hanna Parnas; Itzchak Parnas
Journal:  J Neurosci       Date:  2002-05-01       Impact factor: 6.167

7.  Adenosine decreases both presynaptic calcium currents and neurotransmitter release at the mouse neuromuscular junction.

Authors:  Eugene M Silinsky
Journal:  J Physiol       Date:  2004-05-14       Impact factor: 5.182

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.